Market Overview:
The global dyslexia treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the dyslexia treatment market can be attributed to the increasing prevalence of dyslexia, rising awareness about available treatments, and growing demand for better-quality treatments. The global dyslexia treatment market is segmented by type, application, and region. By type, the market is segmented into oral therapies, parenteral therapies, and other therapies. Oral therapies are further sub-segmented into drugs and supplements. Parenteral therapies are further sub-segmented into injections and infusions. By application, the market is segmented into psychiatric institutions, rehabilitation centers, home care settings,,and others (including schools).
Product Definition:
Dyslexia Treatment is a form of therapy that is used to help people who have dyslexia. The goal of Dyslexia Treatment is to help people learn how to read and write correctly.
Oral:
Oral is a learning disability that affects the ability to read and write. It's major symptoms are difficulty in understanding what the text says, poor memory for facts and names, inability to follow simple instructions, etc. Oral dyslexia mainly occurs in people who have a hard time hearing or understanding speech due to any reason like noise pollution or if they have a hearing problem themselves.
Parenteral:
Parenteral is a route of administration used to introduce drugs and fluids into the body. It can be oral or non-oral. The most common parenteral drug delivery systems are syringes, vials, ampoules and cartridges, droppers, and infusion pumps.
Application Insights:
The others application segment held the largest share of more than 60.0% in 2017. The other applications include diagnostic centers, schools and colleges, hospitals and clinics, and pharmaceutical companies. These institutions provide diagnosis for reading disorders such as dyslexia along with treatment options for these disorders. Diagnostic centers are the primary caretakers of patients suffering from dyslexia or any other speech sound disorder as they undergo a detailed evaluation of each patient to determine the cause of speech sound issues or learning disabilities that may be remedied through therapy sessions conducted at these centers.
Regional Analysis:
North America dominated the global dyslexia treatment market in 2017. The presence of a large number of private and public organizations focused on dyslexia development is one of the major factors contributing to regional growth. For instance, International Dyslexia Foundation (IDF) was established in the U.S. to provide assistance and support for individuals with reading disabilities, their families, and teachers worldwide.
Asia Pacific is expected to witness significant growth over the forecast period owing to increasing awareness among people with regard to available treatments for Dyslexic children along with rising disposable income levels in emerging economies such as India & China which has led towards an increase in demand for various types of therapies including medication that are taken by mouth or via injection etc.
Growth Factors:
- Increasing awareness about dyslexia and its treatment options among people.
- Growing number of research studies on dyslexia and its treatment options.
- Development of new and innovative therapies for dyslexia treatment.
- increasing number of dyslexia clinics and centers across the world.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dyslexia Treatment Market Research Report
By Type
Oral, Parenteral, Others
By Application
Psychiatric Institutions, Rehabilitation Centers, Home Care, Others
By Companies
GlaxoSmithKline, Pfizer, Novrtis, Casper Pharma, Teva Pharmaceutical Industries Ltd., UCB S.A., Alkem Labs, Crecent Therapeutics Limited, Baxter, Intas Pharmaceuticals Ltd., Brown & Burk
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
198
Number of Tables & Figures
139
Customization Available
Yes, the report can be customized as per your need.
Global Dyslexia Treatment Market Report Segments:
The global Dyslexia Treatment market is segmented on the basis of:
Types
Oral, Parenteral, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Psychiatric Institutions, Rehabilitation Centers, Home Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Pfizer
- Novrtis
- Casper Pharma
- Teva Pharmaceutical Industries Ltd.
- UCB S.A.
- Alkem Labs
- Crecent Therapeutics Limited
- Baxter
- Intas Pharmaceuticals Ltd.
- Brown & Burk
Highlights of The Dyslexia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Parenteral
- Others
- By Application:
- Psychiatric Institutions
- Rehabilitation Centers
- Home Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dyslexia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dyslexia treatment typically includes accommodations such as extra time on tests, help with reading materials, and/or specialized instruction.
Some of the key players operating in the dyslexia treatment market are GlaxoSmithKline, Pfizer, Novrtis, Casper Pharma, Teva Pharmaceutical Industries Ltd., UCB S.A., Alkem Labs, Crecent Therapeutics Limited, Baxter, Intas Pharmaceuticals Ltd., Brown & Burk.
The dyslexia treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dyslexia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dyslexia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dyslexia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dyslexia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dyslexia Treatment Market Size & Forecast, 2018-2028
4.5.1 Dyslexia Treatment Market Size and Y-o-Y Growth
4.5.2 Dyslexia Treatment Market Absolute $ Opportunity
Chapter 5 Global Dyslexia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dyslexia Treatment Market Size Forecast by Type
5.2.1 Oral
5.2.2 Parenteral
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dyslexia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dyslexia Treatment Market Size Forecast by Applications
6.2.1 Psychiatric Institutions
6.2.2 Rehabilitation Centers
6.2.3 Home Care
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dyslexia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dyslexia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dyslexia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Dyslexia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dyslexia Treatment Market Size Forecast by Type
9.6.1 Oral
9.6.2 Parenteral
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dyslexia Treatment Market Size Forecast by Applications
9.10.1 Psychiatric Institutions
9.10.2 Rehabilitation Centers
9.10.3 Home Care
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dyslexia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Dyslexia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dyslexia Treatment Market Size Forecast by Type
10.6.1 Oral
10.6.2 Parenteral
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dyslexia Treatment Market Size Forecast by Applications
10.10.1 Psychiatric Institutions
10.10.2 Rehabilitation Centers
10.10.3 Home Care
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dyslexia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dyslexia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dyslexia Treatment Market Size Forecast by Type
11.6.1 Oral
11.6.2 Parenteral
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dyslexia Treatment Market Size Forecast by Applications
11.10.1 Psychiatric Institutions
11.10.2 Rehabilitation Centers
11.10.3 Home Care
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dyslexia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Dyslexia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dyslexia Treatment Market Size Forecast by Type
12.6.1 Oral
12.6.2 Parenteral
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dyslexia Treatment Market Size Forecast by Applications
12.10.1 Psychiatric Institutions
12.10.2 Rehabilitation Centers
12.10.3 Home Care
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dyslexia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dyslexia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dyslexia Treatment Market Size Forecast by Type
13.6.1 Oral
13.6.2 Parenteral
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dyslexia Treatment Market Size Forecast by Applications
13.10.1 Psychiatric Institutions
13.10.2 Rehabilitation Centers
13.10.3 Home Care
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dyslexia Treatment Market: Competitive Dashboard
14.2 Global Dyslexia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Pfizer
14.3.3 Novrtis
14.3.4 Casper Pharma
14.3.5 Teva Pharmaceutical Industries Ltd.
14.3.6 UCB S.A.
14.3.7 Alkem Labs
14.3.8 Crecent Therapeutics Limited
14.3.9 Baxter
14.3.10 Intas Pharmaceuticals Ltd.
14.3.11 Brown & Burk
